ANI Pharmaceuticals to Present at the Cantor Global Healthcare Conference 2023
18 Settembre 2023 - 10:05PM
ANI Pharmaceuticals, Inc. (ANI or the Company) (Nasdaq: ANIP) today
announced that Nikhil Lalwani, Chief Executive Officer, and Stephen
Carey, Chief Financial Officer, will present at the Cantor Global
Healthcare Conference 2023 in New York City as follows:
Date: |
|
Tuesday, September 26, 2023 |
|
|
|
Time: |
|
11:40am ET |
|
|
|
Webcast: |
|
Click here |
|
|
|
To schedule a 1x1 meeting with the Company, please contact
corporateaccess@cantor.com.
The live and archived webcast will be accessible from the
Company’s website at www.anipharmaceuticals.com, under the
Investors section under Events and Presentations. The replay of the
webcast will be accessible for 90 days.
About ANI
ANI Pharmaceuticals, Inc. (Nasdaq: ANIP) is a diversified
biopharmaceutical company serving patients in need by developing,
manufacturing, and marketing high quality branded and generic
prescription pharmaceutical products, including for diseases with
high unmet medical need. Our team is focused on delivering
sustainable growth by scaling up our Rare Disease business through
the successful launch of our lead asset, Purified Cortrophin® Gel,
strengthening our generics business with enhanced development
capability, innovation in established brands and leveraging our
North American manufacturing capabilities. For more information,
please visit our website www.anipharmaceuticals.com.
Investor Relations: Lisa M. Wilson, In-Site
Communications, Inc.T: 212-452-2793 E: lwilson@insitecony.com
Source: ANI Pharmaceuticals, Inc.
Grafico Azioni ANI Pharmaceuticals (NASDAQ:ANIP)
Storico
Da Mag 2024 a Giu 2024
Grafico Azioni ANI Pharmaceuticals (NASDAQ:ANIP)
Storico
Da Giu 2023 a Giu 2024